Mashup Score: 2
library.ehaweb.orgEHA Library; Magnusson T. Jun 9 2021; 324632;
See more from Akiva Diamond
Retrospective Flatiron EMR data presented at EHA2021 showed no difference in OS in 154 DH/THL patients treated with RCHOP vs EPOCH. 4 years OS was 54.5% vs vs. 49.6%, respectively. Single hit MYC-R patients had even worse outcomes.